ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
2 2025
Изменен: 30.04.2025Путь: Главная / Публикации
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
11401 11402 11403 11404 11405 11406 9644 11291 11407 11408 7666 11409 11410 11411 11412 2 2025
Изменен: 30.04.2025Путь: Главная / Басты бет / Жарияланымдар
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
... et al. Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. N Engl J Med. 2017;377(15):1448–1455. doi.10.1056/NEJMoa1704053 5. Jumabayeva A., Nersesov A., Kulzhanov M. et al. Prevalence of Viral Hepatitis B, C, and D in Kazakhstan. Sci World J. 2022;2022:9102565. doi:10.1155/2022/9102565 6. KDIGO Hepatitis C Work Group. KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl. 2018;8(3):91–165 7. Kumada H., Watanabe T., Suzuki F., et al. Efficacy ...
Изменен: 30.04.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 3 из 3
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате